DIRECT IN-VIVO ASSESSMENT OF PARATHYROID HORMONE-CALCIUM RELATIONSHIPCURVE IN RENAL PATIENTS

Citation
P. Messa et al., DIRECT IN-VIVO ASSESSMENT OF PARATHYROID HORMONE-CALCIUM RELATIONSHIPCURVE IN RENAL PATIENTS, Kidney international, 46(6), 1994, pp. 1713-1720
Citations number
36
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00852538
Volume
46
Issue
6
Year of publication
1994
Pages
1713 - 1720
Database
ISI
SICI code
0085-2538(1994)46:6<1713:DIAOPH>2.0.ZU;2-#
Abstract
Secondary hyperparathyroidism (SHP) is a well documented finding even in the early stages of chronic renal failure (CRF). A sigmoidal relati onship, fitting a four parameter model, links PTH secretion rate and c alcium concentration changes. To our knowledge, PTH secretory paramete rs have only been studied in uremic patients who are in dialysis treat ment. As a result of these studies, a possible role for derangement in setpoint values (that is, the serum calcium concentration correspondi ng to the mid-range value on the sigmoidal curve) has been suggested i n the pathogenesis of SHP in CRF. Our study was undertaken to gain ins ight into the calcium-PTH relationship curve in the first course of CR F and to assess whether a change in any of the secretory parameters is related to the beginning of SHP. We studied 27 male renal patients wi th a variable degree of renal function (creatinine clearance 12 to 164 ml/min) and 9 control subjects. In all patients and controls the foll owing parameters were evaluated: (1) basal 1,25(OH)(2) vitamin D, 25(O H)vitamin D, calcitonin (CT), intact PTH; (2) GFR by Cr(51)EDTA cleara nce; (3) the sigmoidal PTH-ionized calcium relation curve, by means of a hypocalcemic stimulating test (Na-2-EDTA 37 mg/kg body weight/2 hr) and a hypercalcemic test (Ca gluconate giving 8 mg/kg of body weight/ 2 hr of Ca element), performed on two consecutive days. The main resul ts were: (1) the progressive reduction of GFR was accompanied by an in crease in the maximum secretory capacity of PTH, without any change in setpoint values; (2) in addition to the already known factors, CT see ms to be, in some as yet undefined way, related to PTH hypersecretion in the course of CRF.